Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.00
-0.02-1.96%
At close: -
$1.06
0.066.00%
After Hours: 9:18 AM EDT
Comments
Loading...
RenovoRx Analyst Ratings and Price Targets | NASDAQ:RNXT | Benzinga
RenovoRx Inc has a consensus price target of $7.25 based on the ratings of 5 analysts. The high is $13 issued by Roth MKM on August 18, 2023. The low is $3 issued by HC Wainwright & Co. on March 27, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Ascendiant Capital, and Ascendiant Capital on March 27, 2025, December 10, 2024, and September 12, 2024, respectively. With an average price target of $6.75 between HC Wainwright & Co., Ascendiant Capital, and Ascendiant Capital, there's an implied 536.79% upside for RenovoRx Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Ascendiant Capital
Alliance Global Partners
Roth MKM
1calculated from analyst ratings
Analyst Ratings for RenovoRx
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/27/2025 | Buy Now | 183.02% | HC Wainwright & Co. | Swayampakula Ramakanth49% | → $3 | Initiates | → Buy | Get Alert |
| 12/10/2024 | Buy Now | 749.06% | Ascendiant Capital | Edward Woo53% | $8.25 → $9 | Maintains | Buy | Get Alert |
| 09/12/2024 | Buy Now | 678.3% | Ascendiant Capital | Edward Woo53% | $8 → $8.25 | Maintains | Buy | Get Alert |
| 06/17/2024 | Buy Now | 654.72% | Ascendiant Capital | Edward Woo53% | → $8 | Initiates | → Buy | Get Alert |
| 02/02/2024 | Buy Now | 277.36% | Alliance Global Partners | Scott Henry47% | → $4 | Initiates | → Buy | Get Alert |
| 11/15/2023 | Buy Now | — | Maxim Group | Jason McCarthy42% | — | Downgrade | Buy → Hold | Get Alert |
| 08/18/2023 | Buy Now | 1126.42% | Roth MKM | Scott Henry47% | $14 → $13 | Maintains | Buy | Get Alert |
FAQ
What is the target price for RenovoRx (RNXT) stock?
The latest price target for RenovoRx (NASDAQ:RNXT) was reported by HC Wainwright & Co. on March 27, 2025. The analyst firm set a price target for $3.00 expecting RNXT to rise to within 12 months (a possible 183.02% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for RenovoRx (RNXT)?
The latest analyst rating for RenovoRx (NASDAQ:RNXT) was provided by HC Wainwright & Co., and RenovoRx initiated their buy rating.
When was the last upgrade for RenovoRx (RNXT)?
There is no last upgrade for RenovoRx
When was the last downgrade for RenovoRx (RNXT)?
The last downgrade for RenovoRx Inc happened on November 15, 2023 when Maxim Group changed their price target from N/A to N/A for RenovoRx Inc.
When is the next analyst rating going to be posted or updated for RenovoRx (RNXT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of RenovoRx, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for RenovoRx was filed on March 27, 2025 so you should expect the next rating to be made available sometime around March 27, 2026.
Is the Analyst Rating RenovoRx (RNXT) correct?
While ratings are subjective and will change, the latest RenovoRx (RNXT) rating was a initiated with a price target of $0.00 to $3.00. The current price RenovoRx (RNXT) is trading at is $1.06, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.